iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

Stockholders' Equity (Details)																		1 Months Ended					3 Months Ended			5 Months Ended	6 Months Ended	9 Months Ended
Stockholders' Equity (Details)	Apr. 01, 2020 USD ($) shares	Mar. 31, 2020 USD ($) $ / shares shares	Mar. 19, 2020 USD ($) $ / shares shares	Oct. 29, 2019 USD ($) $ / shares shares	Oct. 28, 2019 USD ($) $ / shares shares	Jul. 12, 2018 USD ($) $ / shares shares	Jun. 26, 2018 USD ($) $ / shares shares	Jun. 20, 2018 $ / shares shares	Jan. 26, 2018	Nov. 27, 2017	Jul. 24, 2017 USD ($) item $ / shares shares	Feb. 23, 2017 USD ($) $ / shares shares	Apr. 13, 2016 USD ($) shares	Apr. 07, 2016 shares	Jan. 25, 2016 USD ($) shares	Jan. 13, 2016 USD ($) $ / shares shares	Jan. 14, 2014	Mar. 31, 2020 USD ($) $ / shares shares	Mar. 31, 2019 shares	Nov. 30, 2018 USD ($)	May 31, 2018 USD ($)	Mar. 31, 2018 USD ($) shares	Mar. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2019 shares	Mar. 31, 2019 USD ($) shares	Mar. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2019 shares	Mar. 31, 2020 USD ($) $ / shares shares	Mar. 31, 2019 USD ($) shares	Feb. 20, 2020 shares	Sep. 30, 2019 shares	Jun. 30, 2019 USD ($) $ / shares shares	Dec. 31, 2018 shares	Sep. 30, 2018 shares	Jun. 30, 2018 shares	Dec. 19, 2017 shares	Dec. 31, 2015
Stockholders' Equity [Line Items]
Term of agreement																	5 years
Issuance of common stock to underwriters (in shares)							4,350,000
Warrant exchange \| $																							$ 0
Warrants to purchase shares of Common Stock																														9,595,002
Exercise of warrants																										29,100,000	14,999,998
Proceeds from exercise of warrants \| $																										$ 6,400,000		$ 6,330,000	$ 0
Shares of common stock issued for the cashless exercise of Warrants																										5,900,000
Cashless exercise of warrants reducing balance owed for notes payable - warrant exchange \| $																										$ 1,300,000		$ 1,304,000	0
Costs related to the warrant exchange offset against additional paid-in capital \| $																										$ 313,000
Warrants outstanding		0																0					0			0		0
Preferred Stock, Shares Authorized		1,000,000																1,000,000					1,000,000			1,000,000		1,000,000
Shares exchanged for ownership interest												29,990,000
Acquisition Of Equity Interest, Units Receivable Per Preferred Share																												29,990,000
Common Stock, Par or Stated Value Per Share \| $ / shares		$ 0.001																$ 0.001					$ 0.001			$ 0.001		$ 0.001				$ 0.001
Stock Issued During Period, Value, New Issues \| $							$ 16,000,000																		$ 0
Common Stock, Shares Authorized		275,000,000																275,000,000					275,000,000			275,000,000		275,000,000				275,000,000
Common Stock, Capital Shares Reserved for Future Issuance		3,100,000																3,100,000					3,100,000			3,100,000		3,100,000
Proceeds from Issuance of Common Stock \| $				$ 4,520,000
Agreement term																	5 years
Common Stock, Shares, Issued		107,360,032									120,000							107,360,032					107,360,032			107,360,032		107,360,032				20,152,458
Share Price \| $ / shares		$ 1.06					$ 0.90											$ 1.06					$ 1.06			$ 1.06		$ 1.06
Underwriting Discounts, Commissions and Other Offering Expenses \| $						$ 159,000	$ 854,000
No sales period							90 days
Underwriting option period							45 days
Proceeds from Warrant Exercises \| $																										$ 6,400,000		$ 6,330,000	$ 0
Proceeds from Noncontrolling Interests \| $																				$ 2,459,000	$ 1,093,000
Stock Issued During Period, Shares, Warrants Exercised																										29,100,000	14,999,998
Series A Warrants [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)				25,000,000
Exercise of warrants																											3,300,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares				$ 0.22
Number of stocks sold				1
Number of warrants issued				25,000,000
Exercise price of warrants \| $ / shares				$ 0.22
Term of the warrants				2 years
Stock Issued During Period, Shares, Warrants Exercised																											3,300,000
Series B Warrants [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)				25,000,000
Exercise of warrants																											6,600,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares				$ 0.22
Number of stocks sold				1
Number of warrants issued				25,000,000
Exercise price of warrants \| $ / shares				$ 0.22
Term of the warrants				7 years
Stock Issued During Period, Shares, Warrants Exercised																											6,600,000
Common Stock [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)				2,450,000			4,350,000																		142,000
Warrant exchange \| $																							$ 15,000
Warrant exchange (in shares)																							15,000,000
Exercise of warrants																							31,860,000	3,140,000
Shares Issued, Price Per Share \| $ / shares							$ 0.90	$ 0.90
Stock Issued During Period, Value, New Issues \| $																									$ 0
Conversion of Stock, Shares Issued				22,550,000																								5,887,997
Common Stock, Shares Authorized																																				275,000,000
Shares, Outstanding		107,360,000																107,360,000	19,602,000				107,360,000	54,567,000	19,602,000	107,360,000	54,567,000	107,360,000	19,602,000		24,152,000	20,152,000	18,837,000	18,337,000	16,040,000
Number of stock issued on each unit of stock sold				1
Stock Issued During Period, Shares, Warrants Exercised																							31,860,000	3,140,000
Preferred Stock [Member]
Stockholders' Equity [Line Items]
Warrant exchange \| $																							$ 0
Stock Issued During Period, Value, New Issues \| $																									$ 0
Shares, Outstanding		6,000																6,000	10,000				6,000	6,000	10,000	6,000	6,000	6,000	10,000		6,000	10,000	11,000	11,000	12,000
Warrant [Member]
Stockholders' Equity [Line Items]
Number of stocks sold				2
Common Stock and Warrants [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share \| $ / shares				$ 0.20
Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Acquisitions												1
Shares exchanged for ownership interest												1
Preferred Stock, Dividend Rate, Percentage																												2.00%
Preferred Stock, Dividends Per Share, Declared \| $ / shares																												$ 0
Dividends Payable \| $		$ 806,000																$ 806,000					$ 806,000			$ 806,000		$ 806,000				$ 610,000
Preferred Stock, Par or Stated Value Per Share \| $ / shares												$ 0.001
Series A Preferred Stock [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)							6,300
Preferred Stock, Shares Authorized		6,300						1,000,000										6,300					6,300			6,300		6,300				6,300
Convertible Preferred Stock, Terms of Conversion																												Each share of Series A Preferred was convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price in effect at such time. The original conversion price of $0.90 was adjusted to $0.20 upon the closing of the Company's public offering on October 29, 2019. See the sections below entitled "Public Offering - June 26, 2018" and "Public Offering - October 29, 2019" for further information. The number of shares of common stock to be received was limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series A Preferred would not have the right to exercise any portion of its Series A Preferred if such holder, together with its affiliates, would beneficially own over 4.99% of the number of shares of our common stock outstanding immediately after giving effect to such exercise; provided, however, that upon 61 days' prior notice to us, such holder may increase such limitation, provided that in no event will the limitation exceed 9.99%.
Dividends Payable \| $		$ 0																$ 0					$ 0			$ 0		$ 0
Preferred Stock, Par or Stated Value Per Share \| $ / shares								$ 0.001
Maximum ownership through conversion without prior notice								4.99%
Notice period								61 days
Maximum ownership through conversion with prior notice								9.99%
Conversion of Stock, Shares Converted																												3,987
Share Price \| $ / shares							$ 1,000	$ 1,000
Series B Preferred Stock [Member]
Stockholders' Equity [Line Items]
Maximum Common Stock Percentage								48.00%
Issuance of common stock to underwriters (in shares)							5,785
Preferred Stock, Shares Authorized		5,785						1,000,000										5,785					5,785			5,785		5,785				5,785
Convertible Preferred Stock, Terms of Conversion																												Each share of Series B Preferred is convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price in effect at such time. The original conversion price of $0.90 was adjusted to $0.20 upon the closing of the Company's public offering on October 29, 2019. See the sections below entitled "Public Offering - June 26, 2018" and "Public Offering - October 29, 2019" for further information. The number of shares of common stock to be received is limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series B Preferred will not have the right to exercise any portion of its Series B Preferred if such holder, together with its affiliates, would beneficially own over 48% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Dividends Payable \| $		$ 0																$ 0					$ 0			$ 0		$ 0
Preferred Stock, Par or Stated Value Per Share \| $ / shares								$ 0.001
Shares Issued, Price Per Share \| $ / shares				$ 0.20				0.90
Conversion of Stock, Shares Converted																												0
Conversion Of Preferred Stock, Conversion Price Per Share \| $ / shares																												$ 0.20
Common Stock, Capital Shares Reserved for Future Issuance		28,925,000																28,925,000					28,925,000			28,925,000		28,925,000
Share Price \| $ / shares							$ 1,000	$ 1,000
Series C Preferred Stock [Member]
Stockholders' Equity [Line Items]
Maximum Common Stock Percentage					4.99%
Issuance of common stock to underwriters (in shares)				4,510
Preferred Stock, Shares Authorized		4,510			1,000,000													4,510					4,510			4,510		4,510				4,510
Convertible Preferred Stock, Terms of Conversion																												Each share of Series C Preferred was convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price of $0.20, subject to adjustment. The number of shares of common stock to be received was limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series C Preferred would not have the right to exercise any portion of its Series C Preferred if such holder, together with its affiliates, would beneficially own over 4.99% (or, upon election by a holder prior to the issuance of any Series C Preferred Shares, 9.99%) of the number of shares of our Common Stock outstanding immediately after giving effect to such exercise; provided, however, that upon prior notice to us, such holder may increase such limitation, provided that in no event will the limitation exceed 9.99% and any such increase would not be effective until the 61st day after such notice was delivered to the Company.
Dividends Payable \| $					$ 0
Preferred Stock, Par or Stated Value Per Share \| $ / shares					$ 0.001
Common Stock, Par or Stated Value Per Share \| $ / shares					1,000
Shares Issued, Price Per Share \| $ / shares					$ 0.20
Maximum ownership through conversion without prior notice, prior to the issuance of preferred shares					9.99%
Series C Preferred Shares, and Warrants [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share \| $ / shares				$ 1,000
Over-Allotment Option [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)						1,500,000
Shares Issued, Price Per Share \| $ / shares						$ 0.90
Stock Issued During Period, Value, New Issues \| $						$ 1,350,000
Proceeds from Issuance of Common Stock \| $						$ 1,350,000
Sale Of Stock Number Of Shares Offered For Sale							2,666,666
Underwritten offering
Stockholders' Equity [Line Items]
Proceeds from Issuance of Common Stock \| $				$ 5,000,000
Eastern Share Purchase Agreements [Member]
Stockholders' Equity [Line Items]
Term of agreement							2 years						3 years
Maximum Common Stock Percentage									48.00%	38.00%						38.00%
Issuance of common stock to underwriters (in shares)													650,000	650,000		650,000
Proceeds from exercise of warrants \| $																$ 945,000
Stock Issued During Period, Shares, Acquisitions																350,000
Shares Issued, Price Per Share \| $ / shares																$ 6.22
Stock Issued During Period, Value, New Issues \| $													$ 4,043,000		$ 2,177,000
Equity Method Investment, Ownership Percentage										40.00%
Agreement term							2 years						3 years
Class Of Warrants Or Rights Exercised															178,400
Proceeds from Warrant Exercises \| $																$ 945,000
Lincoln Park Purchase Agreement [Member]
Stockholders' Equity [Line Items]
Maximum Common Stock Percentage											9.99%
Share Price \| $ / shares											$ 0.25
Stock Issued During Period, Shares, Other											10,000
Number of days since last purchase											1 day
Number of closing prices \| item											3
Number of consecutive trading days											10 days
Number of shares remaining																							14,878,710
Maximum [Member] \| Lincoln Park Purchase Agreement [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)											1,000,000
iBio CDMO LLC [Member]
Stockholders' Equity [Line Items]
Shares exchanged for ownership interest												1
Eastern Affiliate [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)																650,000
Equity Method Investment, Ownership Percentage									40.00%
Lincoln Park Capital Fund, LLC [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Issued or Sold											1,781,479
Shares, Outstanding											8,911,851
iBio CMO [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Amount Represented by Preferred Stock \| $																$ 15,000,000
Noncontrolling Interest, Ownership Percentage by Parent												99.99%																									100.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners																70.00%
iBio CMO [Member] \| Eastern Affiliate [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners												0.01%
Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Value, New Issues \| $												$ 13,000,000
Convertible Preferred Stock, Shares Issued upon Conversion												29,990,000
Lincoln Park Capital Fund, LLC [Member]
Stockholders' Equity [Line Items]
Term of agreement											36 months								36 months
Issuance of common stock to underwriters (in shares)											250,000											60,000
Noncontrolling Interest, Ownership Percentage by Parent											19.99%
Stock Issued During Period, Value, New Issues \| $																						$ 121,290
Aggregate Common Stock Purchased \| $											$ 16,000,000
Agreement term											36 months								36 months
Percentage of available shares issued											3.00%
Share Price \| $ / shares											$ 4.00
Lincoln Park Capital Fund, LLC [Member] \| Maximum [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased \| $											$ 1,000,000
Lincoln Park 2020 Purchase Agreement
Stockholders' Equity [Line Items]
Term of agreement			36 months
Maximum obligation under each Regular Purchase \| $			$ 5,000,000
Floor price \| $ / shares			$ 0.20
Maximum Common Stock Percentage			19.99%
Issuance of common stock to underwriters (in shares)		5,000,000	815,827															5,000,000										15,000,000
Maximum ownership through conversion without prior notice			9.99%
Proceeds from Issuance of Common Stock \| $		$ 5,766,000																$ 5,800,000										$ 15,700,000
Aggregate Common Stock Purchased \| $			$ 50,000,000
Agreement term			36 months
Sale Of Stock Number Of Shares Offered For Sale			1,000,000
Lincoln Park 2020 Purchase Agreement \| Subsequent event
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)	10,000,000
Proceeds from Issuance of Common Stock \| $	$ 9,962,600